What surveillance strategies, in the context of cardiovascular disease, optimize early detection, assessment, and monitoring of patients with suspected or confirmed FD?
What surveillance strategies, in the context of cardiovascular disease, optimize early detection, assessment, and monitoring of patients with suspected or confirmed FD?
Presenter
Jay M. Sullivan Endowed Chair in Cardiovascular Medicine
Chief of Cardiology
University of Tennessee Health Science Center (UTHSC)
Co-Director, UT Methodist Institute for Cardiovascular Science
University of Tennessee Heart Institute
Memphis, TN